Delivery Order SPE2DB20D1100-SPE2DB25FD6E4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Janumet XR 100-1,000 mg tablets (30-count) valued at $1,002.54. The contract, awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,866.22 to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180-count) on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Janumet XR 50-1,000 mg tablets in a quantity of 180 units. This delivery order, valued at approximately $39,906, represents a firm fixed-price contract with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,086.48 to supply Janumet XR 100-1,000 mg tablets (90-count) with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order under a larger contract vehicle. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $3,032.22 firm fixed price delivery order to AmerisourceBergen Drug Corp for 180 tablets of Janumet XR 50-1,000 mg, with an ultimate completion date of July 29, 2025. This non-set-aside competitive award was issued on July 28, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide JANUMET XR 100-1,000 MG TABLET 90S. The $16,017.25 order was issued on May 18, 2022, with a completion date of May 19, 2022. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...
- The Defense Logistics Agency awarded a delivery order valued at $9,376.56 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (60-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,874.29 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of JANUMET XR 50-1,000 mg tablets in 60-count packages. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for...
- The Defense Logistics Agency awarded a $9,327.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 180 tablets of Janumet XR 50-1,000 mg, with an ultimate completion date of July 22, 2025. This non-set-aside award was issued on July 21, 2025, and represents a pharmaceutical supply delivery to support federal medical procurement needs. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed-price contract with a ceiling value of $1,673.93. This is a non-set-aside competitive award with an ultimate completion date of July 25, 2025. The vendor will perform the delivery order from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD6E4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at approximately $61.2K to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180-count units). This contract, which was competitively awarded with no set-aside designation, became effective on July 24, 2025, with an ultimate completion date of July 25, 2025. The firm fixed-price delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. This prime vehicle serves as a comprehensive pharmaceutical support mechanism enabling AmerisourceBergen to supply an expansive range of medications, vaccines, and medical supplies to military healthcare systems globally. The current delivery order for Janumet XR—a combination diabetes medication—exemplifies the contractor's role in supporting the Defense Health Agency's pharmaceutical procurement requirements and reflects the company's established capability to fulfill federal medical supply needs across multiple therapeutic domains through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $61.2k | 7/24/25 |